Polaris Greystone Financial Group LLC boosted its holdings in Danaher Corporation (NYSE:DHR) by 1.2% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 235,824 shares of the conglomerate’s stock after acquiring an additional 2,835 shares during the quarter. Danaher Corporation accounts for about 2.3% of Polaris Greystone Financial Group LLC’s investment portfolio, making the stock its 16th largest position. Polaris Greystone Financial Group LLC’s holdings in Danaher Corporation were worth $19,901,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. BlackRock Inc. increased its stake in Danaher Corporation by 2,530.9% in the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock worth $3,247,398,000 after acquiring an additional 36,524,795 shares during the last quarter. Flossbach Von Storch AG increased its stake in Danaher Corporation by 44.7% in the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock worth $487,945,000 after acquiring an additional 1,785,810 shares during the last quarter. Vanguard Group Inc. increased its stake in Danaher Corporation by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock worth $3,503,962,000 after acquiring an additional 1,530,015 shares during the last quarter. MARSHALL WACE ASIA Ltd bought a new position in Danaher Corporation in the 1st quarter worth about $116,462,000. Finally, Marshall Wace North America L.P. bought a new position in Danaher Corporation in the 1st quarter worth about $116,462,000. Institutional investors and hedge funds own 75.69% of the company’s stock.
Danaher Corporation (NYSE:DHR) opened at 87.17 on Wednesday. The company has a market capitalization of $60.56 billion, a price-to-earnings ratio of 27.82 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.62. The stock’s 50 day moving average price is $85.42 and its 200 day moving average price is $84.17.
Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. During the same period in the previous year, the firm posted $0.90 earnings per share. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. Equities research analysts anticipate that Danaher Corporation will post $3.96 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be paid a dividend of $0.14 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.64%. Danaher Corporation’s payout ratio is currently 17.83%.
In other Danaher Corporation news, insider William King sold 7,458 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total transaction of $618,790.26. Following the sale, the insider now directly owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the sale, the director now directly owns 42,151 shares in the company, valued at $3,499,797.53. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock worth $5,916,223 over the last three months. 12.20% of the stock is currently owned by insiders.
A number of brokerages have weighed in on DHR. Morgan Stanley restated an “overweight” rating and issued a $95.00 target price (up from $86.00) on shares of Danaher Corporation in a research note on Friday, October 6th. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a research note on Thursday, October 5th. J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research report on Friday, September 8th. Cowen and Company reiterated a “buy” rating and set a $90.00 price objective on shares of Danaher Corporation in a research report on Wednesday, October 4th. Finally, Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $83.00 price objective on shares of Danaher Corporation in a research report on Tuesday, September 26th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $92.62.
WARNING: “Danaher Corporation (DHR) Shares Bought by Polaris Greystone Financial Group LLC” was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://stocknewstimes.com/2017/10/11/danaher-corporation-dhr-shares-bought-by-polaris-greystone-financial-group-llc.html.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.